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Ventral Striatal Activation During Reward Processing
in Psychosis
A Neurofunctional Meta-Analysis
Joaquim Radua, MD, BStat, PhD; André Schmidt, PhD; Stefan Borgwardt, MD, PhD; Andreas Heinz, MD, PhD;
Florian Schlagenhauf, MD; Philip McGuire, MD, PhD; Paolo Fusar-Poli, MD, PhD
IMPORTANCE Abnormal reward processing is suggested to underlie the formation of
psychotic symptoms, likely driven by elevated ventral striatal (VS) dopamine levels.
Functional magnetic resonance imaging studies reveal alterations of VS activity during reward
processing in patients with chronic psychosis and first episode of psychosis, as well as
individuals at high risk for psychosis, but findings are inconclusive, conflicting, and difficult to
subject to meta-analysis without introducing bias because several studies reported that
findings were not statistically significant but did not report statistics.
OBJECTIVE To assess the differences between patients with schizophrenia spectrum
disorders and healthy controls in VS activation during reward processing.
DATA SOURCES Web of Knowledge database (incorporatingWeb of Science andMEDLINE)
until July 2015, including references of eligible articles and reviews.
STUDY SELECTION Functional magnetic resonance imaging studies comparing VS activity
during monetary reward processing between patients with schizophrenia spectrum disorders
or clinical or genetic high-risk state for psychosis and healthy controls.
DATA EXTRACTION AND SYNTHESIS Statistics and thresholds related to themain outcome
measures and potential moderators were independently retrieved by 2 investigators. Effect
sizes were analyzed using MetaNSUE, a random-effects method that enables the unbiased
inclusion of nonstatistically significant unreported effects.
MAIN OUTCOMES ANDMEASURES Effect size of the group differences in VS activity, and
correlation between VS activity and negative and positive symptom scores in patients.
RESULTS Themeta-analysis included 23 studies (917 patients) for reward anticipation, 9
studies (358 patients) for reward feedback, and 8 studies (314 patients) for reward prediction
error. We found significant bilateral VS hypoactivation during reward anticipation (23 studies,
n = 917) in patients compared with healthy controls (left/right Cohen d, −0.50/−0.70;
P< .001). Left VS abnormality was more severe in patients with high scores of negative
symptoms during reward anticipation (r=−0.41; P< .001). Patients also showed
hypoactivation during reward feedback (left/right d, −0.57/−0.56; P< .001). Simulations
showed that exclusion of studies with nonstatistically significant unreported effects was
associated with a strong bias (d bias=0.22), whereas estimations using MetaNSUEwere
unbiased even when statistics were seldom reported (d bias < 0.001).
CONCLUSIONS AND RELEVANCE This meta-analysis provides evidence that patients with
psychosis demonstrate VS hypoactivation during reward anticipation. The assessment of VS
prediction errors seems to be promising, but more studies are needed to draw valid
conclusions.
JAMA Psychiatry. 2015;72(12):1243-1251. doi:10.1001/jamapsychiatry.2015.2196
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S tudies frommore thanhalf a centuryagohadalready re-ported that patients with schizophrenia often describehowirrelevant stimuli capture their attentionandareas-
signedundulyhighsignificance.1,2Thisphenomenonwassug-
gested to result from abnormal stimulus-reinforcement for-
mations inducedbychaoticdopaminergic firing inmesolimbic
reward pathways, which could consequently produce psy-
chotic symptoms.3 The phenomenon was later on framed in
termsof “aberrant salience,” aphenomenological conceptpro-
posing that psychosismay arise froman inappropriate assign-
mentof salience to contextually irrelevant external events and
internalmental states.4,5 In this context, salience refers to the
motivational aspect of stimuli, which catch attention be-
cause of their association with primary reinforcement,6 and
is mediated by dopamine in the ventral striatum (VS).6
Recent proposals link aberrant salience to abnormal pre-
diction error processing, driving the formation of reinforce-
ment learning abnormalities and possibly psychotic
symptoms.7,8Predictionerrors, thediscrepancybetweentheac-
tual inputs and the prediction about it, are mediated via mid-
brain dopamine neurons and their targets in the VS.9,10 A con-
temporaryanimalmodelproposed thatpsychosismaydevelop
as a result of an impaired inhibitory functioning of themedial
temporal lobe, leading to elevated VS dopamine level.11 It was
suggested that consequently the number of dopamine neu-
rons participating in providing prediction error signalsmay be
upregulated in schizophrenia, contributing to abnormal sa-
lienceprocessing.11Whereasdiverseneuralmeasureshavebeen
interpreted to reflect aberrant salience attribution in psycho-
sis studies12 up to now,most studies—asmeta-analyzed in this
article—focusedontheprocessingof reward-indicatingcues. In
thiscontext,abluntedresponsebetweenreward-indicatingand
neutral cues was taken as ameasure of aberrant salience.
Positron emission tomography and single-photon emis-
sioncomputedtomographystudieshaveconsistentlyshownthat
striataldopaminesynthesiscapacityis increasedinpsychosis.13,14
Functional magnetic resonance imaging (fMRI) studies during
monetary rewardanticipationhavealsodetectedalteredVSac-
tivation in patients experiencing their first episode of psycho-
sis, patients with chronic psychosis, and individuals at clinical
orgenetichighrisk(HR)forpsychosis.However, thesefMRIfind-
ingsseeminconclusivebecausesomestudies foundreducedVS
activation15-25 whereas others reported no abnormalities.26-37
Similar conflicts are evident for fMRI reward prediction error
studies, with reduced VS activation being found in some
studies38-43 and VS hyperactivation26 or no VS differences in
others.44Additionally, theclinical relevanceofVSalterations in
psychosis is unclear. For example, most of the studies investi-
gated the relation between VS activation and negative symp-
toms,withsomestudiesrevealingsignificantcorrelations15,17,23,28
andothersnot.30,32,40These inconsistenciesmaybeduetosmall
andheterogeneouspatient samples, varying tasks and imaging
analyses, and/or confounding effects of antipsychotic medica-
tion.Unfortunately, thesestudiesaredifficult tosubject tometa-
analysisbecauseseveral studiesstate that findingswerenotsta-
tistically significant without reporting statistics, and attempts
to retrieve unpublished data by contacting authors have been
shown to bemostly (~80%) unsuccessful.45
To address these inconsistencies, we present here, to our
knowledge, the first systematic review and neurofunctional
meta-analysis ofVSactivationduring rewardprocessing inpa-
tients at HR, those experiencing their first episode of psycho-
sis, and those with chronic psychosis. In particular, we fo-
cused on reward anticipation and feedback, aswell as reward
prediction error.We investigated the robustness of themeta-
analytic findingsand theeffectsofpotential clinical andmeth-
odologicalmoderators. In addition,we present an innovative
methodologicalapproachto includeall studiesevenif theyonly
report that they did not find any statistically significant ef-
fect (but not the specific effect size or related statistics).
Methods
Search Strategies
Twoinvestigators (A.S.,P.F.-P.) conductedan independent sys-
tematic 2-step literature search to identify relevant articles.
First, the Web of Knowledge database (incorporating Web of
ScienceandMEDLINE)wassearchedtodetectabstracts inEng-
lish published through July 2015 (keywords: “psychosis,”
“schizophrenia,” “high-risk psychosis,” “salience,” “fMRI,”
“ventral striatum,”“reward,” “predictionerror”). Second, Sco-
pus was used to detect citations of previous systematic re-
views and to perform manual searches of the reference lists
of the retrievedarticles. Identified articleswere then screened
according to the selection criteria. The Meta-analysis of Ob-
servational Studies inEpidemiology (MOOSE) checklist46was
adopted (eTable 1 in the Supplement).
Selection Criteria
Studies were eligible for inclusion if they (1) were original ar-
ticles written in English; (2) compared patients with ICD-10
Classification of Mental and Behavioral Disorders47 and/or
DSM-548 diagnosis of schizophrenia spectrum disorders or
clinical49 or genetic50HRstate for psychosiswithhealthy con-
trols; and (3) investigated fMRI VS responses explicitly dur-
ing monetary reward processing, in particular contrasts ad-
dressing reward anticipation, feedback of reward, or reward
prediction error (Table). If available, multiple contrasts from
the same study were included. Studies were excluded if they
(1) only included anticipationofmonetary loss, aversive feed-
back, and aversive predictive error or other salience-related
contrasts (eTables 2 and3 in the Supplement) or (2) usedover-
lapping data sets16,21 (we included the original and larger data
sets15,17,18 instead of pooled results21).
Asdetailed in theStatisticalAnalysis section,wedidnotex-
clude studies that did not report effect sizes; note that exclu-
sionofstudieswithstatisticallynonsignificantdifferenceswould
bias the meta-analysis toward those studies with large differ-
ences. Literature searchwas summarizedaccording to thePre-
ferred Reporting Items for Systematic Reviews and Meta-
analyses (PRISMA) guidelines (eFigure 1 in the Supplement).51
Recorded Variables
Dataextractionandqualityassessmentwere independentlyper-
formedby2 investigators (A.S., P.F.-P.).The followingvariables
Research Original Investigation Ventral Striatum in Reward Processing in Psychosis
1244 JAMAPsychiatry December 2015 Volume 72, Number 12 (Reprinted) jamapsychiatry.com
Downloaded From: http://archpsyc.jamanetwork.com/ by a Kings College London User  on 06/01/2016
Copyright 2015 American Medical Association. All rights reserved.
Table. Description of the Included Samples
Study
Functional Magnetic Resonance
Imaging Contrast/Learning Model
Patients With Psychosis Controls
Stagea No.
Age,
Mean, y Males, %
Medicated,
% No.
Age,
Mean, y Males, %
Reward Anticipation (Cue Induced)
Abler et al,35 2008 Anticipation of reward vs neutral Chronic
(SZ, SA)
12 36.7 42 100 12 36.2 58
De Leeuw et al,23 2015 Anticipation of reward vs neutral HR (S) 27 31.7 52 0 29 30.3 41
Diaconescu et al,19
2011
Anticipation of reward vs neutral
(with or without conditioned
stimulus)
Chronic (SZ) 13 37.6 77 100 13 36.5 69
Dowd and Barch,29 2012 Anticipation of reward vs neutral Chronic
(SZ, SA)
25 31.4 72 100 20 33.2 70
Esslinger et al,20 2012b Anticipation of reward vs neutral FEP (SZ, SA, D) 27 27.8 74 0 27 27.1 74
Gilleen et al,31 2015 Anticipation of reward vs neutral Chronic (SZ) 20 36.5 100 95 12 30.7 100
Grimm et al,22 2014 Anticipation of reward vs neutral HR (FGR) 54 33.6 43 0 80 33.5 49
Juckel et al,15 2006 Anticipation of reward vs neutral Chronic (SZ),
FGA
10 31.5 80 100 10 30.6 80
Chronic (SZ),
SGA
10 37.6 60 100
Juckel et al,34 2012 Anticipation of reward vs neutral HR (BS, SIPS) 13 25.5 85 46 13 25.7 85
Mucci et al,30 2015 Anticipation of reward vs neutral Chronic (SZ) 28 33.1 64 100 22 31.9 45
Nielsen et al,24 2012 Overall salience contrast (uncertain
reward + uncertain loss greater
than certain neutral + certain
neutral)
FEP (SZ, SA) 31 25.9 71 0 31 25.7 71
Nielsen et al,25 2012 Overall salience contrast (uncertain
reward + uncertain loss greater
than certain neutral + certain
neutral)
FEP (SZ) 23 26.0 70 0 24 25.7 83
Roiser et al,32 2013 Adaptive salience (high-probability
rewarding vs low-probability
rewarding cues
HR (ARMS) 18 25.7 39 0 18 26.5 56
Schlagenhauf et al,17
2008
Anticipation of reward vs neutral Chronic (SZ),
FGA
10 30.5 90 100 10 31.8 90
Schlagenhauf et al,18
2009
Anticipation of reward vs neutral Chronic (SZ) 15 30.1 80 0 15 30.1 80
Silva Alves et al,36 2013 Anticipation of reward vs neutral Chronic (SZ) 10 22.7 100 100 12 34.5 100
Simon et al,27 2010 Anticipation of reward vs neutral Chronic
(SZ, SA)
15 26.3 67 100 15 25.2 67
Smieskova et al,37
2015b
Adaptive salience (high-probability
rewarding vs low-probability
rewarding cues)
FEP (P) 29 25.9 66 41 19 26.4 53
HR (ARMS) 34 24.3 76 0
Walter et al,26 2009 Anticipation of reward vs neutral Chronic (SZ) 16 38.0 50 100 16 33.0 44
Waltz et al,28 2010 Anticipation of reward vs loss Chronic (SZ) 17 37.8 76 100 17 37.8 71
Wotruba et al,33 2014 Anticipation of reward vs neutral HR (BS, SIPS) 21 25.1 71 0 24 23.3 54
Total 478 30.2 67 42 439 30.2 64
Reward Feedback (Outcome Induced)
Abler et al,35 2008 Feedback of reward vs omission of
reward
Chronic
(SZ, SA)
12 36.7 42 100 12 36.2 58
De Leeuw et al,23 2015 Feedback of reward vs omission of
reward
HR (S) 27 31.7 52 0 29 30.3 41
Dowd and Barch,29 2012 Feedback of reward vs omission of
reward
Chronic
(SZ, SA)
25 31.4 72 100 20 33.2 70
Gilleen et al,31 2015 Feedback of reward vs loss Chronic (SZ) 20 36.5 100 95 12 30.7 100
Nielsen et al,24 2012 Feedback of reward vs omission of
reward
FEP (SZ, SA) 31 25.9 71 0 31 25.7 71
Schlagenhauf et al,18
2009
Feedback of reward vs omission of
reward
Chronic (SZ) 15 30.1 80 0 15 30.1 80
Simon et al,27 2010 Feedback of reward vs omission of
reward
Chronic
(SZ, SA)
15 26.3 67 100 15 25.2 67
Waltz et al,28 2010 Feedback of reward vs omission of
reward
Chronic (SZ) 17 37.8 76 100 17 37.8 71
Wotruba et al,33 2014 Feedback of reward vs omission of
reward
HR (BS, SIPS) 21 25.1 71 0 24 23.3 54
Total 183 30.8 70 48 175 29.6 65
(continued)
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were recorded from each article: reference, sample sizes, age,
sex, illnessstage,antipsychotic treatments, typeofanalysis (“re-
gionof interest” [ROI]vswhole-brain), statistical thresholds,VS
group differences (eg, t values), publication year, clinical and
methodological itemsobjectivelyusedtocalculatequalityscores
(eTable 4 in the Supplement), and correlations betweenVSac-
tivity and negative and/or positive symptoms.
Notably, whole-brain studies did not report the mean VS
effect but thepeakVSeffect. This latter effect is larger than the
meanVS effect, and its usewould thus bias themeta-analysis.
To address this issue, whole-brain coordinates and t values of
themaximawere introduced intoanisotropiceffect-size signed
differential mapping52,53 in order to recreate the image of ef-
fect sizebasedonthecorrelationsbetweenadjacentvoxels, and
the mean effect of all voxels with any probability of being lo-
cated in the nucleus accumbens according to the Harvard-
Oxford atlas54 was then extracted. To overcome the potential
downward bias associated to this estimation,53 maps were
scaled to make differences with ROI studies minimal. Also,
analyses were repeated after only including the latter.
Statistical Analysis
As noted, some studies with nonsignificant group differ-
ences did not report any statistics (eg, t, F, or P values) that
could be converted into effect sizes. Exclusion of these find-
ings (“nonstatistically significantunreportedeffects” [NSUEs])
would bias the meta-analysis—taken to the extreme, includ-
ing only the 3 studies reporting differences but excluding the
1000 studies not detecting any difference (as detailed in the
eMethods section in the Supplement,we also empirically test
this bias with simulations). Inclusion of studies with NSUEs
by assuming them to have a null effect size would be a more
conservative option but still not free from bias.53
Tocorrectly includestudieswithNSUEsintometa-analyses,
wedevelopedanewmethod, calledMetaNSUE,basedonmul-
tiple imputationsalgorithms.55 First, theMetaNSUEcalculates
the bounds of nonstatistical significance of each study with
NSUEs (ie, theunreported tvalueor rcoefficientmustbewithin
these bounds) and converts them to unbiased effect sizes (Co-
hendor z)usingastandard formula.53 Second,anestimationof
theparametersforsubsequentimputationsisconductedbymaxi-
mizing the likelihood that the reported effect sizes have those
values, aswell as the likelihood that theunreportedeffect sizes
arewithin thosebounds.Relevantly, theseparameters include
the between-study heterogeneity (ie, random differences be-
tweenstudiesbeyond thosedue to sampling) andpotential co-
variatesused to individuallypredict theexpectedeffect sizeof
eachstudy(withorwithoutNSUEs).Third,multiple imputations
Table. Description of the Included Samples (continued)
Study
Functional Magnetic Resonance
Imaging Contrast/Learning Model
Patients With Psychosis Controls
Stagea No.
Age,
Mean, y Males, %
Medicated,
% No.
Age,
Mean, y Males, %
Reward Prediction Error
Gradin et al,40 2011 State action reward state action Chronic (SZ) 14 42.5 79 79 17 40.6 41
Koch et al,43 2010 Temporal difference learning
(positive prediction error/positive vs
negative prediction error)
Chronic (SZ) 19 35.2 63 95 20 29.7 60
Morris et al,41 2012 Rewardc surprise interaction
(incorrectly predicted
reward greater than correctly
predicted reward; correctly
predicted nonreward greater
than incorrectly predicted
nonreward)
Chronic (SZ, SA) 16 33.0 56 100 16 32.9 50
Murray et al,38 2008b Standard reinforcement learning
algorithm (prediction error on
reward vs prediction error on
neutral)
FEP (SZ, BD,
PNOS)
13 26.0 69 62 12 26.0 75
Schlagenhauf et al,42
2014
Rescorla-Wagner model FEP (SZ) 24 27.5 92 0 24 27.2 92
Walter et al,26 2009 Receipt of high greater than receipt
of low greater than receipt of
no greater than omission of
low greater than omission of high
reward
Chronic (SZ) 16 38.0 50 100 16 33.0 44
Waltz et al,39 2009 Temporal difference errors
(positive-negative contrast)
Chronic (SZ, SA) 18 37.7 72 100 18 37.1 78
Wolf et al,44 2014 Unpredictable reward vs loss
outcomes
Chronic (SZ, SA) 41 41.7 54 98 37 39.2 49
Total 155 35.7 66 78 159 33.9 61
Abbreviations: ARMS, at-risk mental state; BD, bipolar disorder with psychosis;
BS, basic symptoms; D, delusional disorder; FEP, first-episode psychosis; FGA,
first-generation antipsychotic; FGR, first-grade relatives of schizophrenic
patients; HR, high risk; SGA, second-generation antipsychotic; SIPS, structured
interview for prodromal symptoms; P, psychosis of unspecified type; PNOS,
psychosis not otherwise specified; S, siblings of schizophrenic patients; SA,
schizoaffective; SZ, schizophrenia.
a Individuals were deemed to have genetic risk if they were (1) FGRs or (2) Ss.
The clinical HR state was defined according to international and well-validated
criteria detailed elsewhere,50 which include (1) attenuated psychotic
symptoms, (2) brief and limited intermittent psychotic symptoms, (3) genetic
risk and deterioration syndrome, and (4) BS.
b These studies (may have) included patients with diagnoses other than SZ, SA,
or schizophreniform disorders.
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of theunreportedeffect sizesare randomlycreatedaccordingto
theexpectedvalue (within- andbetween-study), variance, and
statistical significance bounds of each studywith NSUEs. This
stepisneededtocreaterealistic“noisy”imputationsbecauseim-
puting the unreported effect sizes using their expected value
wouldmeanassumingthatwithin-studyvariabilityandbetween-
studyheterogeneity arenull. Finally, a standardmeta-analysis
isseparatelyconductedforeachsetof imputedeffectsizesusing
restrictedmaximum-likelihoodrandom-effectmodels,56andre-
sults fromthesemeta-analysesarepooledusingastandard for-
mula formultiple imputations.57
Empirical validation using simulations showed that esti-
mationswerestronglybiasedwhenconductingastandardmeta-
analysiswithoutNSUEs (dbias = 0.22),moderately negatively
biased when converting NSUEs to zeros (d bias = −0.07), and
nearly unbiased when using MetaNSUE (d bias < 0.001, even
when statistics were seldom reported). See eMethods in the
Supplement for details of the procedure and the validation.
A separatemeta-analysiswas conducted for groupdiffer-
ences in left and right VS activation. Robustness of these dif-
ferenceswas assessedby studying thebetween-studyhetero-
geneity,estimating thepotential reportingbias (metaregression
by standard error to detectwhether results from small impre-
cise studies might have been reported only if they were
significant58-60), and conducting jackknife analyses (ie, itera-
tively repeating themeta-analysis with all studies but 1 in or-
der todetectwhether resultsmaybedrivenby a single study).
Differences between left and right group differences in acti-
vationwere also investigated, alongwith subgroups (medica-
tion-free, patients, HR individuals, ROI studies) and metare-
gressions by mean age, percentage of males, percentage of
medicatedpatients, publicationyear, andquality score.Meta-
analysis of the correlations betweenpsychotic symptomsand
VSactivationwasalsoconducted.Finally,weperformedanex-
ploratory analysis treating all 3 domains (anticipation/
feedback and prediction error) together.
On thebasisof the resultsof theempirical validation,mod-
eratorvariableswere included inthemaximum-likelihoodstep.
All findings with P < .05 are reported as trends, but given the
multiple tests conducted (3 different reward processing do-
mains and 2 brain sides), only those at P ≤ .05/6 = .008 were
considered statistically significant.
Results
Reward Anticipation
This meta-analysis included 23 studies (n = 917) (see Table),
with reported group differences in 7 (left) and 9 (right) stud-
ies, and NSUEs in the remaining studies. Patients showed sig-
nificant hypoactivation in both left and right VS (d left/
right = −0.50/−0.70; P < .001 in both cases) (Figure). No
Figure. Forest Plots of the Ventral StriatumResponse to Reward Anticipation in Psychosis
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Left ventral striatum hypoactivationA
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In studies with knownmeasures, symbols show themean, and error bars, the
95% confidence interval (CI). Studies with nonstatistically significant
unreported effects are distinguished by the presence of a shaded bar around
themean showing the interval containing 95% of the imputed effect sizes; the
central symbol shows themean, and the error bars, the 95% CI. Size of the data
marker corresponds to the relative weight assigned in the pooled analysis.
FEP indicates first episode of psychosis; FGA, first-generation antipsychotic;
HR, individuals at high risk for schizophrenia; and SGA, second-generation
antipsychotic. The location of the ventral striatum is indicated for reference.
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residual heterogeneity or potential reporting bias was
observed (P = .12-.92). Jackknife analyses showed similar
hypoactivation when any single study was discarded (left
d range, −0.45 to −0.58; right d range, −0.66 to −0.77;
P < .001 in all cases) or when themeta-analysis was restricted
to studies inmedication-free patients or to studies using ROIs
(left/right d = −0.45/−0.72 and −0.59/−0.65, respectively;
P < .001 in all cases). No differences were detected between
left and right VS (P = .18). No effects of age, sex, antipsychotic
medication use, publication year, or quality score were
observed (P = .14 to >.99). Similar hypoactivation was found
in patients and HR individuals (left/right d = −0.55/−0.67 vs
−0.44/−0.78; P = .53/.57).
Eleven studies analyzed the correlation between VS acti-
vationandnegative symptoms,15,17,23,24,27-30,32,33 andwewere
able to retrieve thecorrelationcoefficient in5 (left) and2 (right)
studies,with the remaining studies reportingNSUEs. Left hy-
poactivation was more pronounced in patients with higher
negative symptoms (r = −0.41;P < .001), aneffect thatwasnot
evident at the right VS (P = .86). No residual heterogeneity or
potential reporting biaswas observed (P = .35-.96). Jackknife
analyses (only conducted for left VS) showed similar correla-
tions when any single study was discarded (r range, −0.36 to
−0.45; P < .003 in all cases).
Six studies had investigated the relationship with posi-
tive symptoms20,23,24,27,32,33 and wewere able to retrieve the
correlation coefficient in 2 (left) and 3 (right) studies,with the
remaining studies reporting NSUEs. No relationship between
VS activation and positive symptoms could be detected
(P = .47-.79), although this result should be taken with cau-
tion because only 6 studies could be included and there was
residual heterogeneity among them (left/right: I2 = 63%/
72%; P = .03/.003, probably due to studies reporting oppo-
site findings).
Reward Feedback
This meta-analysis included 9 studies (n = 358) (Table), with
reported group differences in 1 study, and NSUEs in the re-
maining studies. Patients showed significant hypoactivation
in both left and right VS ( left/right d= −0.57/−0.56; P < .001)
(eFigure 2 in the Supplement), and no residual heterogeneity
orpotential reportingbiaswasobserved (P = .89-.93).Onemay
wonder that a single study makes the meta-analysis statisti-
cally significant. However, it must be noted that the empiri-
cal validation showed that MetaNSUE’s false-positive rate is
not increased when only 1 study reports significant differ-
ences. That said, jackknife analyses showed similar hypoac-
tivation when any study with NSUEs was discarded (left
d range, −0.59 to−0.64; rightd range, −0.57 to−0.62;P < .001
inall cases)butnodifferences if theonly studydetectinggroup
differences23 was discarded (P = .95-.96), indicating a lower
replicability of this finding, which should thus be taken with
caution. No differences were detected between left and right
VS (P = .72).Nometa-regression analyseswere conductedbe-
cause of the high probability that the study detecting differ-
ences behaved as a leverage point. No relationshipwithnega-
tive or positive symptoms could be observed (eResults in the
Supplement).
Reward Prediction Error
This meta-analysis included 8 studies (n = 314) (Table), with
reported between-group differences in 4 (left) and 6 (right)
studies, andNSUEs in the remaining studies. Patients showed
hypoactivation in both left and right VS (left/right d = −0.28/
−0.53) (eFigure 3 in the Supplement), although not statisti-
cally significant at the left and only at trend level
(.008 < P < .05)at the right side (left/rightP = .37/.01).This lack
of significance should be taken with caution because only 8
studies were included, and there was residual high heteroge-
neity (which decreases the precision and thus the statistical
significanceof the estimates) among them(I2 = 83%and64%;
P < .001 and .02). No potential reporting bias was observed
(P = .12-.76). Jackknife analyses (only conducted for right VS)
showedrelativelysimilarhypoactivationwhenanysinglestudy
was discarded (d range, −0.39 to −0.62; all P < .06). Differ-
ences between left and right VS were not statistically signifi-
cant (P = .53).Nometaregressionanalyseswere conductedbe-
cause of the paucity of studies. No relationshipwith negative
or positive symptoms could be observed (eResults in the
Supplement).
Combination of Reward Anticipation, Feedback,
and Prediction Error
Resultsof thisexploratoryanalysisareexplained intheeResults
in the Supplement.
Discussion
Ourmeta-analysis revealed that psychosiswas robustly asso-
ciatedwithVShypoactivationduring reward anticipation, in-
cluding 23 studies with 917 participants, whereas no residual
heterogeneity, potential reporting bias, or jackknife abnor-
malities have been detected. Meta-analyses of reward feed-
back and prediction error also showed VS hypoactivation but
should be carefully considered, because findingswere driven
by a single study in the first (although validation showed an
excellent control of the false-positive rate) and were not sta-
tistically significant in the second (probably due to between-
study heterogeneity). No differenceswere observed between
left and right VS in any of the reward processes. Our meta-
analysis further showed that left VS activation during reward
anticipation was negatively correlated with negative symp-
toms in patients.
The robust findingofVShypoactivationduring rewardan-
ticipationmay support that psychosis is characterized by im-
paired learning of stimulus-reinforcement associations.7,61
However, studiesof rewardanticipationdidnot investigate the
learning process directly but rather the neural response to re-
ward-indicating cues learned before scanning, and thus our
finding may reflect a more general blunting of VS responsiv-
ity rather than a specific deficit during reinforcement learn-
ing.Theattributionof incentive salience to rewardingcueshas
been proposed to be mediated by phasic dopamine increase
in the striatum and contributes to the wanting of reward.6 A
recent meta-analysis has shown that striatal presynaptic do-
paminergicmarkers are consistently altered in psychosis.13,62
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In chronicpsychosis,13,63 andalready in clinicalHRsubjects,64
striatal dopamine levels are elevated in the absence of incom-
ing stimuli,whichmaysteer theassignmentof salience tonor-
mally irrelevant stimuli whose presence happens to tempo-
rally coincidewith dopamine release.4,65Moreover, a chaotic
stress-associated striatal dopamine release5,7 may also im-
pedeaphasicdopamine release in response tocontextually rel-
evant (eg, reward indicating) cues, leading to decreased dif-
ferentiation between the responses to relevant and irrelevant
stimuli.65 In this framework, theVShypoactivationduring re-
ward anticipation can be taken as a measure of altered sa-
lience processing because it reflects a blunted response to-
ward reward-indicatingcomparedwithneutral cues.However,
general caution is recommended in relating dopamine re-
lease to neural activation because they are often not mea-
sured in the same region (elevateddopamine levels havebeen
found in the associative striatum63,64 and different VS defini-
tions are used across studies) and also because fMRI signals
have limited statistical relationships to neurochemical
markers.66 For example, sophisticated attempts to relate VS
fMRIsignalsduringrewardanticipationwithmeasuresofdopa-
mine release induced by monetary incentive delay task have
revealedmixed results.67,68 TheDiscussion section should be
read with this caveat in mind.
We found thatpatients also showeda trend for rightVShy-
poactivationduring rewardprediction error processing.How-
ever, the robustness of thismeta-analysiswas limitedby a rel-
evant between-studyheterogeneity,which is probably due to
thedifferent reinforcement learningalgorithm,38,40,42 and the
diverse psychological task designs and contrasts used across
studies.26,39,41,43 Previous studies inhealthyparticipants com-
bining fMRI and positron-emission tomography measures
showed that the right VS prediction error signal is negatively
associatedwithVSpresynaptic dopamine level.69,70Wecould
thus speculate that the elevated striatal dopamine level in
psychosis14might be associatedwith the rightVShypoactiva-
tion during prediction error processing that we found. In line
with this argumentation, a behavioralmeasure of aberrant sa-
lience attribution (derived from the salience attribution task),
which is heightened in patients with schizophrenia,71 was
found to be positively correlated with striatal dopamine syn-
thesis capacityandnegativelycorrelatedwith fMRIstriatalpre-
diction errors signal in health controls.72
Current antipsychotic drug use was not found to moder-
ate the reducedVSactivationduring rewardanticipation.How-
ever, most studies included patients treated with both typi-
cal and atypical antipsychotics, and it has beenproposed that
theeffectof severalatypicaldrugsmayresult fromadopamine-
mediated attenuation of aberrant salience processing,4,65
whereas typical but not atypical drugshavebeen shown to re-
ducetheVSresponsetoreward-indicatingstimuli.15 In linewith
this finding, a recent meta-analysis in psychosis did not find
a significant modulation of antipsychotics on striatal dopa-
mine synthesis capacity.13,62
We found that left VS hypoactivation during reward
anticipation was more pronounced in patients with higher
negative psychotic symptoms in accordance with evidence
from a previous meta-analysis.73 Our correlation findings
thus suggest that VS hypoactivation may impair the positive
and motivational effect of rewarding events and in turn pro-
mote negative symptoms.5 This corresponds with a first
pilot study, which suggested that decreased left VS activa-
tion is inversely correlated with the severity of negative
symptoms in antipsychotic-free patients.16 The authors sug-
gested that high striatal dopamine turnover may increase
the “noise” in the reward system, thus interfering with the
neuronal processing of reward-predicting cues by phasic
dopamine release.16 This, in turn, may lead to negative
symptoms, which group in 2 factors, one involving dimin-
ished expression of affect and alogia and the second involv-
ing avolition including anhedonia and asociality.74 Our find-
ings may also have some translational effects, given that
negative psychotic symptoms are refractory to all available
treatments.75 However, this conclusion requires further
research given that there is also evidence showing that
dopamine function in the VS was inversely correlated with
negative symptom severity.63 Furthermore, the relation
between VS activation during reward anticipation and posi-
tive symptoms requires further investigation because only 6
studies were available and there was residual heterogeneity
among them.
This study has some limitations. Findings of VS hypoac-
tivation during reward feedback and prediction error, as
well as the correlation with positive symptoms, are less
robust than the hypoactivation during reward anticipation
or the correlation with negative symptoms and should be
taken with caution until more studies are available; the first
finding might also reflect that VS activation is not crucially
involved during the feedback phase in the monetary incen-
tive delay task.76 We could not explore whether group dif-
ferences may be due to negative symptoms. Region of inter-
est delimitation was slightly heterogeneous across studies,
resulting in different VS definitions. Similarly, recreation of
images from peak t values may not be free from downward
bias,53 although maps were scaled and analyses were
repeated after only including the latter. To contain consis-
tency in fMRI contrasts, we focused on rewarding stimuli
without considering anticipation of monetary loss, aversive
feedback, and aversive predictive error or other salience-
related contrasts due to the high heterogeneity of these con-
trasts; however, a preliminary meta-analysis during loss
anticipation revealed bilateral VS hypoactivation in psy-
chotic patients, suggesting that VS hypoactivation in psy-
chosis may be associated with a general deficit in salience
processing (eTable 2 in the Supplement). More studies are
needed to support this finding. The present analysis was
restricted to the VS given its relevance during reward pro-
cessing and psychosis.12 However, the VS does not function
in isolation during reward processing and future studies
should consider this process from a network perspective.77
A whole-brain analysis will be of interest when more whole-
brain studies are available. Finally, the lack of a significant
effect in the moderator variable for disease stage does not
necessarily mean that no differences exist between the
groups. More studies for each group, particularly for the HR
group, are needed to draw robust inferences.
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Conclusions
This meta-analysis demonstrates reduced VS activation dur-
ing reward anticipation in psychosis, which supports altered
processing of salient reward-indicating stimuli. We further
showed that the VS dysfunction during reward prediction is
correlatedwith negative symptoms.More studies are needed
to assess whether the abnormality also affects reward feed-
back and prediction error.
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